keyword
MENU ▼
Read by QxMD icon Read
search

orthovisc

keyword
https://www.readbyqxmd.com/read/29026341/benefits-of-different-postoperative-treatments-in-patients-undergoing-knee-arthroscopic-debridement
#1
Cesáreo Trueba Vasavilbaso, Carlos David Rosas Bello, Erla Medina López, Maria Pilar Coronel Granado, José Mario Navarrete Álvarez, Cesáreo Angel Trueba Davalillo, Félix Isaac Gil Orbezo
PURPOSE: To assess the effectiveness of viscosupplementation or platelet-rich plasma (PRP), compared to standard care, for pain relief after knee arthroscopic debridement in patients with meniscal pathology and osteoarthritis (OA), under normal clinical practice conditions. PATIENTS AND METHODS: We conducted a prospective, randomized, evaluator-blind, pilot study. After arthroscopy, patients were randomized to receive 1) five injections of HA1 (Suprahyal(®)/Adant(®)); 2) four injections of HA2 (Orthovisc(®)); 3) three injections of HA3 (Synvisc(®)); 4) a single injection of PRP (GPS™ II); or 5) standard care (control)...
2017: Open Access Rheumatology: Research and Reviews
https://www.readbyqxmd.com/read/28744035/therapeutic-efficacy-of-three-hyaluronic-acid-formulations-in-young-and-middle-aged-patients-with-early-stage-meniscal-injuries
#2
Bahar Dernek, Fatma Nur Kesiktas, Tahir Mutlu Duymus, Demirhan Diracoglu, Cihan Aksoy
[Purpose] To investigate and compare the efficacy of three hyaluronic acid formulations in patients with early-stage meniscal injuries. [Subjects and Methods] Male and female patients who were admitted to our clinic between January 2013 and December 2013, diagnosed with early-stage meniscus lesions of the knee, and given a hyaluronic acid treatment were included in this retrospective study. Patients were categorized into 3 groups according to their treatments: MONOVISC, OSTENIL PLUS, or ORTHOVISC. Scores from a Visual Analog Scale and the Western Ontario and McMaster Universities Arthritis Index were evaluated at baseline and one, three, and six months after baseline...
July 2017: Journal of Physical Therapy Science
https://www.readbyqxmd.com/read/28217782/receptor-for-hyaluronan-mediated-motility-rhamm-hmmr-is-a-novel-target-for-promoting-subcutaneous-adipogenesis
#3
S B Bahrami, C Tolg, T Peart, C Symonette, M Veiseh, J U Umoh, D W Holdsworth, J B McCarthy, L G Luyt, M J Bissell, A Yazdani, E A Turley
Hyaluronan, CD44 and the Receptor for Hyaluronan-Mediated Motility (RHAMM, gene name HMMR) regulate stem cell differentiation including mesenchymal progenitor differentiation. Here, we show that CD44 expression is required for subcutaneous adipogenesis, whereas RHAMM expression suppresses this process. We designed RHAMM function blocking peptides to promote subcutaneous adipogenesis as a clinical and tissue engineering tool. Adipogenic RHAMM peptides were identified by screening for their ability to promote adipogenesis in culture assays using rat bone marrow mesenchymal stem cells, mouse pre-adipocyte cell lines and primary human subcutaneous pre-adipocytes...
March 1, 2017: Integrative Biology: Quantitative Biosciences From Nano to Macro
https://www.readbyqxmd.com/read/27403194/clinical-and-cost-outcomes-from-different-hyaluronic-acid-treatments-in-patients-with-knee-osteoarthritis-evidence-from-a-us-health-plan-claims-database
#4
Vinod Dasa, Mitch DeKoven, Kainan Sun, Allan Scott, Sooyeol Lim
BACKGROUND: Intra-articular injection of hyaluronic acid (HA) for knee osteoarthritis (OA) effectively reduces pain and delays total knee replacement (TKR) surgery; however, little is known about relative differences in clinical and cost outcomes among different HA products. OBJECTIVE: To compare disease-specific costs and risk of TKR among patients receiving different HA treatments in a commercially insured cohort of patients with knee OA in the USA. METHOD: Retrospective analyses using IMS Health's PharMetrics Plus Health Plan Claims Database were conducted by identifying knee OA patients with claims indicating initiation of HA treatment at an 'index date' during the selection period (2007-2010)...
2016: Drugs in Context
https://www.readbyqxmd.com/read/27071650/characterization-of-viscosupplementation-formulations-using-chemical-exchange-saturation-transfer-viscocest
#5
Mohammad Haris, Anup Singh, Sanjana Reddy, Puneet Bagga, J Bruce Kneeland, Fotios P Tjoumakaris, Hari Hariharan, Francesco M Marincola, Ravinder Reddy
BACKGROUND: Osteoarthritis (OA) is characterized by progressive loss of cartilage in joints, and is a major cause of pain and disability, and imposes significant health care expense. New therapies are being developed to treat the symptomatic effect of OA, one of which is intra-articular injection of viscosupplementations of different forms of hyaluronic acid (HA). The current study evaluates the chemical exchange saturation transfer (CEST) effect from two popular viscosupplementations [Hylan gf-20 (Synvisc) and hyaluronan (Orthovisc)] by targeting the exchangeable hydroxyl protons present on these molecules (ViscoCEST)...
April 12, 2016: Journal of Translational Medicine
https://www.readbyqxmd.com/read/23514620/hyaluronic-acid-nanoparticles-titrate-the-viscoelastic-properties-of-viscosupplements
#6
Amir Fakhari, Quang Phan, Santosh V Thakkar, C Russell Middaugh, Cory Berkland
Hyaluronic acid (HA) is a glycosaminoglycan with diverse biomedical applications including viscosupplementation of synovial fluid for the treatment osteoarthritis. Current HA viscosupplements such as Synvisc, Orthovisc, and Hyalgan have shown positive effects of reducing pain and improving joint function. The therapeutic efficacy, however, is highly transient, and these viscous fluids suffer from poor injectability. HA nanoparticles were found to modify the rheological properties of a model of the HA viscosupplement Orthovisc...
April 30, 2013: Langmuir: the ACS Journal of Surfaces and Colloids
https://www.readbyqxmd.com/read/23074461/intra-articular-viscosupplementation-with-hylan-g-f-20-to-treat-osteoarthritis-of-the-knee-an-evidence-based-analysis
#7
(no author information available yet)
OBJECTIVE: To assess the effectiveness and cost-effectiveness of hylan G-F 20 as a substitute for existing treatments for pain due to osteoarthritis (OA) of the knee, other viscosupplementation devices, and/or as an adjunct to conventional therapy. Hylan G-F 20 (brand name Synvisc, which is manufactured by Genzyme) is a high molecular weight derivative of hyaluronan, a component of joint synovial fluid. It acts as a lubricant and shock absorber. It is administered by injection into the joint space to treat pain associated with OA of the knee...
2005: Ontario Health Technology Assessment Series
https://www.readbyqxmd.com/read/22577566/hyaluronan-does-not-affect-bupivacaine-s-inhibitory-action-on-voltage-gated-potassium-channel-activities-in-bovine-articular-chondrocytes
#8
William Hester, Jinnan Yang, Guo-Yong Wang, Sen Liu, Michael J O'Brien, Felix H Savoie, Zongbing You
Objectives. The objective of this paper is to determine if hyaluronan affects bupivacaine's anesthetic function. Methods. Whole cell patch clamp recordings were performed on bovine articular chondrocytes cultured in 60 mm dishes. The chondrocytes were treated with phosphate-buffered saline (control group), 7.5 mg/mL hyaluronan (Orthovisc), 0.25% bupivacaine, or a mixture of 7.5 mg/mL hyaluronan and 0.25% bupivacaine. Outward currents were elicited by step depolarization from -90 mV to 150 mV with 5 mV increments and holding for 200 ms...
2012: Advances in Orthopedics
https://www.readbyqxmd.com/read/21197309/intra-articular-hyaluronans-the-treatment-of-knee-pain-in-osteoarthritis
#9
Victor M Goldberg, Laura Goldberg
The etiology of pain in osteoarthritis is multifactoral, and includes mechanical and inflammatory processes. Intra-articular injections of hyaluronans (HAs) are indicated when non-pharmacological and simple analgesics have failed to relieve symptoms. The HAs appear to reduce pain by restoring both mechanical and biomechanical homeostasis in the joint. There are five FDA-approved injectable preparations of HAs: Hyalgan(®), Synvisc(®), Supartz(®), Orthovisc(®) and Euflexxa(®). They all appear to relieve pain from 4 to 14 weeks after injection and may have disease-modification properties...
May 10, 2010: Journal of Pain Research
https://www.readbyqxmd.com/read/21047602/intra-articular-sodium-hyaluronate-injections-in-the-osteoarthritic-ankle-joint-effects-safety-and-dose-dependency
#10
RANDOMIZED CONTROLLED TRIAL
Angelique G H Witteveen, Inger N Sierevelt, Leendert Blankevoort, Gino M M J Kerkhoffs, C Niek van Dijk
BACKGROUND: To determine the efficacy, safety and dose dependency of intra-articular Orthovisc(®) hyaluronic acid injections in the ankle. METHODS: A prospective single blinded study in patients with symptomatic ankle-osteoarthritis. Patients were randomly allocated to 1, 2, 3 ml, or 3 weekly injections of 1 ml (3 × 1 ml). Primary outcome was 'pain during walking' at 15 weeks measured on a 100mm VAS. RESULTS: Twenty-six patients (ITT) participated...
December 2010: Foot and Ankle Surgery: Official Journal of the European Society of Foot and Ankle Surgeons
https://www.readbyqxmd.com/read/19060514/-intra-articular-sodium-hyaluronate-injections-after-arthroscopic-debridement-for-osteoarthritis-of-the-knee-a-prospective-randomized-controlled-study
#11
RANDOMIZED CONTROLLED TRIAL
Nurettin Heybeli, Mahmut Nedim Doral, Ozgür Ahmet Atay, Gürsel Leblebicioğlu, Akin Uzümcügil
OBJECTIVES: The purpose of this study was to evaluate the effect of intra-articular hyaluronic acid (HA) injections after arthroscopic debridement on pain and functional parameters in patients with mild-to-moderate knee osteoarthritis. METHODS: Sixty-seven patients (21 men, 46 women; mean age 56 years; range 40 to 65 years) who underwent standard arthroscopic debridement for primary knee osteoarthritis of Kellgren-Lawrence grade II-III were randomly assigned to HA injections (n=33) or to only follow-up as controls (n=34)...
August 2008: Acta Orthopaedica et Traumatologica Turcica
https://www.readbyqxmd.com/read/18798990/arthroscopic-debridement-of-the-osteoarthritic-knee-combined-with-hyaluronic-acid-orthovisc-treatment-a-case-series-and-review-of-the-literature
#12
Xinning Li, Agam Shah, Patricia Franklin, Renee Merolli, Jill Bradley, Brian Busconi
OBJECTIVE: An evaluation of safety and efficacy of high molecular weight hyaluronan (HA) delivered at the time of arthroscopic debridement of the osteoarthritic knee. METHODS: Thirty consecutive patients who met inclusion and exclusion criteria underwent arthroscopic debridement by a single surgeon and concomitant delivery of 6 ml/90 mg HA (Orthovisc). These patients were evaluated preoperatively, at 6 weeks, 3 and 6 months post-operatively. Evaluations consisted of WOMAC pain score, SF-36 Physical Component Summary (PCS) score and complications...
2008: Journal of Orthopaedic Surgery and Research
https://www.readbyqxmd.com/read/18180567/-the-use-of-arthroscopic-debridement-and-viscosupplementation-in-knee-osteoarthritis
#13
RANDOMIZED CONTROLLED TRIAL
Cağatay Uluçay, Faik Altintaş, Ender Ugutmen, Burak Beksaç
OBJECTIVES: We investigated the effectiveness of arthroscopic debridement followed by viscosupplementation using different hyaluronic acid (HA) products in selected patients with knee osteoarthritis. METHODS: The study included 77 women (mean age 50+/-5 years; range 40 to 60 years) who had mild knee osteoarthritis according to the modified ARA (American Rheumatism Association) criteria and Ahlback classification. All the patients had degenerative meniscal tears...
November 2007: Acta Orthopaedica et Traumatologica Turcica
https://www.readbyqxmd.com/read/17874246/what-is-the-evidence-for-viscosupplementation-in-the-treatment-of-patients-with-hip-osteoarthritis-systematic-review-of-the-literature
#14
REVIEW
Michel P J van den Bekerom, Bas Lamme, An Sermon, Michiel Mulier
INTRODUCTION: Osteoarthritis (OA) is a disease of the synovial joints and is the most common cause of chronic pain in the elderly. One of the treatment modalities for OA of the hip is viscosupplementation (VS). Today there are several different formulations of viscosupplements produced by different manufactures of different molecular weights. The objective of this review is to asses the efficacy of VS treatment of hip OA osteoarthritis in the current literature. MATERIAL AND METHODS: The following databases were searched: Medline (period 1966 to November 2006), Cochrane Database of Systematic Reviews (1988 to November 2006), Cochrane Clinical Trial Register (1988 to November 2006), Database of Abstracts on Reviews and Effectiveness, Current Controlled Trials, National Research Register and Embase (January 1988 to November 2006)...
August 2008: Archives of Orthopaedic and Trauma Surgery
https://www.readbyqxmd.com/read/16625635/viscosupplementation-for-the-treatment-of-osteoarthritis-of-the-knee
#15
REVIEW
N Bellamy, J Campbell, V Robinson, T Gee, R Bourne, G Wells
BACKGROUND: Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. OBJECTIVES: To assess the effects of viscosupplementation in the treatment of OA of the knee. The products were hyaluronan and hylan derivatives (Adant, Arthrum H, Artz (Artzal, Supartz), BioHy (Arthrease, Euflexxa, Nuflexxa), Durolane, Fermathron, Go-On, Hyalgan, Hylan G-F 20 (Synvisc Hylan G-F 20), Hyruan, NRD-101 (Suvenyl), Orthovisc, Ostenil, Replasyn, SLM-10, Suplasyn, Synject and Zeel compositum)...
2006: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/16206349/clinical-effects-of-intraarticular-injection-of-high-molecular-weight-hyaluronan-orthovisc-in-osteoarthritis-of-the-knee-a-randomized-controlled-multicenter-trial
#16
RANDOMIZED CONTROLLED TRIAL
David Neustadt, Jacques Caldwell, Mary Bell, John Wade, Joseph Gimbel
OBJECTIVE: To evaluate the efficacy and safety of injection of high molecular weight (HMW) hyaluronan (Orthovisc) in patients with mild, moderate, and severe knee osteoarthritis (OA). METHODS: A randomized, arthrocentesis-controlled, multicenter trial. Patients (n = 372) were randomized to 4 weekly HMW hyaluronan injections (O4, n = 128), 3 weekly HMW hyaluronan injections followed by one arthrocentesis (O3A1, n = 120), or 4 arthrocenteses without injection (control group, A4, n = 124)...
October 2005: Journal of Rheumatology
https://www.readbyqxmd.com/read/15895892/comparison-of-two-hyaluronan-drugs-in-patients-with-advanced-osteoarthritis-of-the-knee-a-prospective-randomized-double-blind-study-with-long-term-follow-up
#17
RANDOMIZED CONTROLLED TRIAL
V Karatosun, B Unver, Z Gocen, A Sen
OBJECTIVES: To compare the long-term effects of high and low molecular weight hyaluronic acid (HA) applications in severe (Kellgren Lawrence stage III) osteoarthritis (OA) of the knee. METHODS: In a prospective clinical trial 184 knees (92 patients) with radiographic Kellgren Lawrence stage III OA were randomized to receive either 3 intra-articular high molecular weight HA (Hylan G-F 20) injections or 3 low molecular weight HA (Orthovisc) injections at one-week intervals...
March 2005: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/15846754/viscosupplementation-for-the-treatment-of-osteoarthritis-of-the-knee
#18
REVIEW
N Bellamy, J Campbell, V Robinson, T Gee, R Bourne, G Wells
BACKGROUND: Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. OBJECTIVES: To assess the effects of viscosupplementation in the treatment of OA of the knee. The products were hyaluronan and hylan derivatives (Adant, Arthrum H, Artz (Artzal, Supartz), BioHy (Arthrease), Durolane, Fermathron, Go-On, Hyalgan, Hylan G-F 20 (Synvisc Hylan G-F 20), NRD-101, Orthovisc, Ostenil, Replasyn, SLM-10, Suplasyn, Synject and Zeel compositum)...
April 18, 2005: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/14730630/effects-of-different-molecular-weight-elastoviscous-hyaluronan-solutions-on-articular-nociceptive-afferents
#19
COMPARATIVE STUDY
Ana Gomis, Matthias Pawlak, Endre A Balazs, Robert F Schmidt, Carlos Belmonte
OBJECTIVE: To compare 3 different hyaluronan (HA) preparations used as therapeutic agents for osteoarthritis pain in humans in order to establish the degree to which a single application affects the sensitivity of nociceptors in both the normal and the acutely inflamed rat joint. METHODS: In anesthetized rats, single-unit recordings were performed from the medial articular nerve of the right knee joint under normal conditions and during an acute experimental arthritis...
January 2004: Arthritis and Rheumatism
https://www.readbyqxmd.com/read/14679274/intra-articular-hyaluronic-acid-in-treatment-of-knee-osteoarthritis-a-meta-analysis
#20
Grace H Lo, Michael LaValley, Timothy McAlindon, David T Felson
CONTEXT: Intra-articular hyaluronic acid is a US Food and Drug Administration-approved treatment for knee osteoarthritis (OA); however, its efficacy is controversial. OBJECTIVE: To evaluate whether intra-articular hyaluronic acid is efficacious in treating knee OA. DATA SOURCES: We searched for human clinical trials in MEDLINE (1966 through February 2003) and the Cochrane Controlled Trials Register, using the search terms (osteoarthritis, osteoarthrosis, or degenerative arthritis) and (hyaluronic acid, Hyalgan, Synvisc, Artzal, Suplasyn, BioHy, or Orthovisc)...
December 17, 2003: JAMA: the Journal of the American Medical Association
keyword
keyword
75848
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"